Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2000
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2368185A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367288A1 Functionalized glycosaminoglycan polymer and medical instruments and drugs by using the same
10/12/2000CA2367109A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000CA2367104A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2367051A1 Use of arylalkanoylpyridazines
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2366807A1 Anti-tumor activity of vitamin e, cholesterol, taxol and betulinic acid derivatives
10/12/2000CA2366787A1 Compositions and methods for treating lymphoma
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/12/2000CA2268588A1 Novel aryl-chloro-ethyl ureas
10/11/2000EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
10/11/2000EP1043318A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
10/11/2000EP1043316A2 Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy
10/11/2000EP1043026A2 Melanoma therapy
10/11/2000EP1043025A2 Renal cell carcinoma treatment
10/11/2000EP1043024A2 Chronic myeloid leukemia (cml) therapy
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042498A1 A method of finding agonist and antagonist to human 11cb splice variant
10/11/2000EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof
10/11/2000EP1042456A1 Human nucleotide pyrophosphohydrolase-2
10/11/2000EP1042365A1 Compounds and methods for modulating occludin related tissue permeability
10/11/2000EP1042362A2 Human regulatory proteins
10/11/2000EP1042360A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/11/2000EP1042354A2 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
10/11/2000EP1042350A1 Inducible phosphofructokinase and the warburg effect
10/11/2000EP1042348A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes
10/11/2000EP1042343A1 Vegi, an inhibitor of angiogenesis and tumor growth
10/11/2000EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines
10/11/2000EP1042328A1 Sarcodictyin and eleutherobin derivatives useful for stabilising microtubles
10/11/2000EP1042327A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
10/11/2000EP1042326A1 Novel acronycine derivatives, preparation method and pharmaceutical compositions
10/11/2000EP1042323A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
10/11/2000EP1042317A1 New pharmaceutically active compounds
10/11/2000EP1042316A1 Indole derivatives useful a.o. for the treatment of osteoporosis
10/11/2000EP1042315A1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042294A1 Heterocyclic cytotoxic agents
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042285A1 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
10/11/2000EP1041991A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/11/2000EP1041985A1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041977A1 USE OF PPAR-$g(g) ACTIVATORS IN DERMATOLOGY
10/11/2000EP0937101B1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
10/11/2000EP0914116B1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
10/11/2000EP0719328B1 Grb3-3 gene, variants and uses thereof
10/11/2000CN1269835A Chimeric interleukin-6 soluble receptor/ligand protein, analoys thereof and uses thereof
10/11/2000CN1269832A Kay-novel immune system protein
10/11/2000CN1269804A CTL epitopes from EBV
10/11/2000CN1269797A Oligo-thiophenes useful as antimetastatic agents, preparation thereof and pharmaceutical composition containing same
10/11/2000CN1269221A Anticarcinogen injecta and its preparation
10/11/2000CN1057297C Waterless crystallization of quinolone derivative and crystallization method of its 3/2 hydrate
10/11/2000CN1057220C Compound anti-cancer Chinese medicine
10/11/2000CN1057219C Chinese herbal medicine composition for treating tumor and cancer
10/10/2000US6130326 L-ribavirin. oh; anticarcinogenic/antitumor agents; viricides; fungicides; treatment of autoimmune diseases
10/10/2000US6130325 Human P24 vesicle proteins
10/10/2000US6130239 Inhibit cyclin-dependent kinases
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000US6130230 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
10/10/2000US6130227 7-Substituted camptothecin derivatives and methods for inhibiting the growth of tumor cells therewith
10/10/2000US6130210 Heparin derivatives having antimetastatic activity
10/10/2000US6130204 Peptides
10/10/2000US6130088 Antisense modulation of telomeric repeat binding factor 1 expression
10/10/2000US6130087 Methods for generating cytotoxic T cells in vitro
10/10/2000US6130064 Amino acid sequence encoded by polynucleotide from survival motor neuron gene; diagnosis, treatment, and prevention of nervous system, reproductive, and cell proliferative disorders; antiproliferative/anticarcinogenic agents
10/10/2000US6130062 Production of proteins in host cells
10/10/2000US6130052 Leukemia associated genes
10/10/2000US6129914 Bispecific antibody effective to treat B-cell lymphoma and cell line
10/10/2000CA2080231C 2'-o-alkylnucleotides as well as polymers which contain such nucleotides
10/10/2000CA1341114C Pharmaceutical formulations containing melphalan hydrochloride
10/08/2000CA2303992A1 Melanoma therapy
10/08/2000CA2303765A1 Cml therapy
10/08/2000CA2303752A1 Renal cell carcinoma treatment
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058512A1 Antisense modulation of interleukin-5 signal transduction
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058483A2 Protozoan expression system
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058470A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058466A2 Protease resistant flint analogs
1 ... 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 ... 2211